Update of triggers for detection of adverse drug events in hematologic patients
This study demonstrated the importance of an updated list of triggers for the monitoring of ADEs and improvement of the care provided.PMID:38126560 | PMC:PMC10740396 | DOI:10.1590/0102-311XPT077923
Source: Cadernos de Saude Publica - Category: International Medicine & Public Health Authors: Íris Pilegi Domingues Milene Rangel da Costa Source Type: research
More News: Brazil Health | Drugs & Pharmacology | Emergency Medicine | Filgrastim | Hematology | Imodium | International Medicine & Public Health | Lidoderm | Loperamide | Neulasta | Neupogen | Study